T3N0 rectal cancer: radiation for all?

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Optimal oncologic management for T3N0 rectal cancer is controversial.
• Pathologic T3N0 disease presents an intermediate risk for recurrence.
• Trimodality therapy may not be universally indicated.

Purpose of the Study:

• To review prognostic factors identifying high-risk T3N0 rectal cancer patients.
• To evaluate the role of preoperative versus postoperative radiation therapy.
• To discuss the implications of clinical understaging on treatment decisions.

Main Methods:

• Review of prognostic indicators for local recurrence in T3N0 rectal cancer.
• Analysis of recent randomized data comparing preoperative and postoperative radiation therapy.
• Consideration of clinical understaging rates and their impact.

Main Results:

• Adverse prognostic features (e.g., deep invasion, poor differentiation) identify high-risk patients.
• Preoperative radiation therapy shows improved local control and disease-free survival compared to selective postoperative therapy.
• Clinical understaging may exceed 20%, necessitating consideration for postoperative radiotherapy.

Conclusions:

• Identifying high-risk T3N0 patients for radiation therapy is crucial.
• Routine preoperative radiation therapy is favored due to improved outcomes and understaging concerns.
• Future studies should stratify patients by prognostic factors and molecular profiles for personalized treatment.